Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.63
+1.35%
Mkt Cap $239.18M
Analyst Ratings
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.25
Range $2.50 – $20.00
Implied Upside
+328.6%
Consensus $11.25 vs current $2.63
NASDAQ·Healthcare·Biotechnology
$2.63
+1.35%
Mkt Cap $239.18M
Buy
3
Hold
0
Sell
0
Price Target (8 analysts)
$11.25
Range $2.50 – $20.00
+328.6%
Consensus $11.25 vs current $2.63